Markel Group Inc. has disclosed a leadership transition at the top of its board, alongside senior executive appointments and compensation changes, in a filing with the U.S. Securities and Exchange Commission. The disclosure spans governance, executive structure and pay, and marks one of the more significant realignments at the insurer and diversified holding company in recent years. What follows draws on the regulatory disclosure and its accompanying press release exhibit.
A three-year notice ends with an immediate handover
Steven A. Markel, the Company’s Chairman of the Board of Directors, provided notice to the Company on September 3, 2026, that (i) he will not stand for re-election as a member of the Board at the 2027 Annual Meeting of Shareholders; and (ii) he will retire as Chairman of the Board (Chairman) upon appointment of his successor. The two-part notice separates the end of his board tenure, which runs to a shareholder meeting still more than a year away, from the chairmanship itself, which changed hands almost immediately. The filing confirms that the Board appointed, on and effective September 8, 2026, the officers named in the same disclosure, closing the gap between notice and handover to less than a week.
The sequencing is notable for a company whose governance has long carried the Markel family name. The notice separates the two events without stating a reason for the sequencing: the board departure is tied to a shareholder meeting more than a year out, while the chairmanship itself passed within days. The filing does not explain why the two timelines were decoupled.
Gayner adds the chairmanship to an existing chief executive role
The board’s choice of successor keeps the chairmanship inside the executive suite rather than handing it to an independent director. Thomas S. Gayner, current Director and Chief Executive Officer of the Company, to the additional role of Chairman, succeeding Mr. Markel, combining the top governance and management positions in a single officer. The arrangement runs counter to the split chairman-and-chief-executive structure that many boards adopted over the past decade under pressure from governance advisers seeking independent board leadership as a check on management.
On top of the combined role, The Board established a Leadership Council, consisting of the Chairman and CEO, the Lead Independent Director, and the Co-Presidents, a body designed to facilitate regular coordination among independent Board leadership and senior management, and enhance the Board and management’s review of the Company’s strategy, performance, and capital allocation. The council formalizes a channel between the newly combined Chairman-and-CEO role, the board’s senior independent director, and the two incoming co-presidents, rather than leaving that coordination to informal contact between offices.
Two co-presidents take charge of insurance and Ventures
The same disclosure elevates two long-serving executives to newly created co-president titles. Simon Wilson, current Executive Vice President and Chief Executive Officer, Markel Insurance, as Co-President and Chief Executive Officer, Markel Insurance, and Andrew G. Crowley, current Executive Vice President and President, Markel Ventures, as Co-President and Chief Executive Officer, Markel Ventures. Both promotions keep each executive running the operating unit he already led — underwriting and specialty insurance on one side, the portfolio of non-insurance operating businesses on the other — while adding a title that now ties each of them formally into the board’s new coordination structure.
Neither appointment moves responsibility across the insurance and non-insurance divide that has defined Markel’s structure for years; each simply elevates the incumbent leader of that division. On the insurance side, the promotion lands as the unit has kept expanding into specialty capacity, including a facility it launched with WTW to cover nuclear risk, and as the business has separately held firm on casualty pricing amid competition from sidecar-backed MGAs.
A compensation package tied to succession
On and effective September 8, 2026, the Compensation Committee of the Board approved increases in base salary for all three executives involved in the realignment: Mr. Gayner, from $1,100,000 to $1,210,000; Mr. Wilson, from $897,967 to $1,083,520; and Mr. Crowley, from $530,000 to $700,000. The filing frames the three raises as a single Compensation Committee action tied to the same effective date as the appointments, rather than as bonuses or one-time succession payments.
Mr. Wilson is paid in Great British Pounds (GBP), reflecting his base running Markel Insurance’s international book, and the dollar figure disclosed for him is based on the conversion rate at September 7, 2026 of 1 GBP to 1.3544 USD rather than a dollar-denominated contract. That conversion detail is a reminder that the co-president structure now spans currencies as well as business lines, with the Compensation Committee disclosing figures in a common denomination for comparability.
The filing’s paper trail
The governance and pay changes were disclosed in the same Form 8-K, under a heading that reads: Retirement of Steven A. Markel as Chairman of the Board; Appointment of Thomas S. Gayner as Chairman of the Board; Appointment of Simon Wilson and Andrew G. Crowley as Co-Presidents. A copy of the press release making these announcements is furnished as Exhibit 99.1 to this Form 8-K, specifically the Press Release issued September 8, 2026. The document carries the signature of Richard R. Grinnan, whose title is listed as Senior Vice President, Chief Legal Officer and Secretary.
Markel Group’s Common Stock, no par value trades under the ticker MKL on the New York Stock Exchange, and the company lists its principal executive offices at 4521 Highwoods Parkway in Glen Allen , Virginia 23060-6148. None of that corporate detail changes with this filing; it simply anchors the disclosure to the entity whose board just changed leadership.
The Markel filing lands in a week of comparable turnover at the top of the sector. In a separate development, a major U.S. insurer restructured its board chair and moved its outgoing chief executive into an advisory role, and in unrelated recent coverage, another large insurance group named a successor to a long-serving reinsurance leader. Neither move is connected to Markel’s announcement beyond timing; each reflects succession planning specific to its own company.
